Bupropion hydrobromide and therapeutic applications

Details for Australian Patent Application No. 2008320915 (hide)

Owner Biovail Laboratories International SRL

Inventors Oberegger, Werner; Saleh, Mohammad Ashty; Maes, Paul; Jackson, Graham

Agent Davies Collison Cave

Pub. Number AU-A-2008320915

PCT Pub. Number WO2009/056550

Priority 11/930,644 31.10.07 US

Filing date 28 October 2008

Wipo publication date 7 May 2009

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/28 (2006.01) Medicinal preparations characterised by special physical form - Dragees

Event Publications

8 April 2010 PCT application entered the National Phase

  PCT publication WO2009/056550 Priority application(s): WO2009/056550

16 February 2012 Alteration of Name

  The name of the applicant has been altered to Valeant International (Barbados) SRL 2009

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008320917-Dispersant for hydraulically setting systems

2008320903-Method of building viscosity and viscoelasticity in surfactant solutions by adding nanoparticles and compositions thereof